COMPANY SPOTLIGHT - Med Immune.

The article presents information on MedImmune Inc. The company operates facilities in the U.S. and Europe to manufacture and distribute one or more components of each of its products. The company focuses its efforts on the areas of infectious disease, oncology and immunology. The company markets four products: Synagis (palivizumab) and FluMist (influenza virus vaccine live, intranasal) to help prevent two common respiratory infectious diseases; Ethyol (amifostine) to help reduce undesired side effects of certain anti-cancer chemo- and radiotherapies; and Cytogam (cytomegalovirus immune globulin intravenous) to help prevent cytomegalovirus disease associated with solid organ transplantation.